One of the most exciting applications of NGS is the development of "liquid biopsies." Traditionally, a cancer diagnosis required a physical tissue biopsy—an invasive procedure that could be painful and sometimes risky. Liquid biopsies, however, detect "circulating tumor DNA" (ctDNA) shed by cancer cells into the bloodstream. This means a simple blood draw can potentially detect cancer at...